Posts

Showing posts from November, 2023

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC ...

Image
cardiovascular failure :: Article Creator Coronary Heart Disease By Age 45 Linked With Later Dementia Younger onset age of coronary heart disease was tied to higher risks of incident all-cause dementia, Alzheimer's disease, and vascular dementia, a large prospective cohort study in Great Britain showed. Each 10-year decrease in coronary heart disease onset age was associated with a 25% increased risk of all-cause dementia, a 29% increased risk of Alzheimer's disease, and a 22% increased risk of vascular dementia (all P<0.001), reported Fanfan Zheng, PhD, of the Chinese Academy of Medical Sciences and Peking Union Medical College in Beijing, and co-authors in the Journal of the American Heart Association. Across all age groups, coronary heart disease diagnosed before age 45 had the highest hazard ratio (HR) for incident dementia compared with people who didn't have coronary heart disease (HR 2.40, P<0.001). "Coronar...

2020 ACC/AHA Guideline for the Management of Patients With ...

Image
pulmonary hypertension janssen :: Article Creator Federal Court Of Appeal And Federal Court Release Three Decisions Relating To Macitentan (Janssen's OPSUMIT) Federal Court of Appeal (FCA) dismisses appeal on finding of inducement: Apotex Inc v Janssen Inc, 2023 FCA 220 Apotex appealed the trial decision, finding that Apo-Macitentan would infringe Canadian Patent No. 2,659,770 (770 Patent). Even though Apotex would only sell Apo-Macitentan by itself, the Federal Court (FC) found that Apotex would induce physicians to prescribe the drug to patients in combination with a phosphodiesterase type-5 inhibitor (PDE5-i) for pulmonary arterial hypertension (PAH). The FC's conclusion was based in part on references in Apotex's product monograph to clinical trial data from the SERAPHIN study, which was the pivotal trial that established the safety and efficacy of macitentan as a monotherapy and as combination therapy with a PDE5-i. The FCA dismi...

VITAMIN D: Overview, Uses, Side Effects, Precautions, Interactions ...

Image
pulmonary inflammatory lesion :: Article Creator Pope Francis Battling Lung Inflammation On Intravenous Antibiotics But Vatican Says His Condition Is "good" Vatican City — Pope Francis was in a "good and stable" condition Monday but was receiving antibiotics intravenously and would limit his activities for a few days to regain strength and fight off a lung inflammation, the Vatican said. The pope, who will turn 87 on Dec. 17, revealed the inflammation on Sunday but said he would still travel later this week to Dubai to address the climate change conference. Francis skipped his weekly Sunday appearance at a window overlooking St. Peter's Square a day after the Vatican said he was suffering from a mild flu. Instead, Francis gave the traditional noon blessing in an appearance televised live from the chapel in the Vatican hotel where he lives. Pope Francis, battling what he said was a lung inflammation, delivers his Sunday Ang...

2022 ACC/AHA Guideline for the Diagnosis and Management of ...

Image
symptoms of graft failure after cabg :: Article Creator Skin Grafts For Leg Ulcers Can Help With Wound Healing, Pain Relief Skin grafts can ease pain associated with leg ulcers and improve wound healing in people with sickle cell disease (SCD), according to a study in France. The procedure consists of the surgical collection of a piece of healthy skin on the body that is then transplanted to the injured area. "Skin grafting could be a temporary solution to avoid therapeutic escalation of analgesics [pain killers], in particular to avoid the use of strong opioids in these patients," researchers wrote. The study, "'SCULP' study: The benefits of skin graft pellets on the pain of sickle cell leg ulcers (SCLU)," was published in JMV-Journal de Médecine Vasculaire. SCD is caused by mutations in the HBB gene, leading to the production of a faulty version of hemoglobin, the protein in red blood cells that carries oxyg...

Evaluation and Management of Pulmonary Hypertension in ...

Image
idiopathic pulmonary fibrosis :: Article Creator Global Idiopathic Pulmonary Fibrosis Management Market To Reach US$ 3649.90 Million By 2033: Focus On Developing New Drugs And TherapiesFMI Idiopathic Pulmonary Fibrosis Management Market During the forecast period of 2023 to 2033, the global idiopathic pulmonary fibrosis management market is anticipated to grow at a CAGR of 1.5% from a market value of US$ 3145 million in 2023 to US$ 3649.90 million. The rising prevalence of the condition in men around the world is responsible for the expansion of the idiopathic pulmonary fibrosis management market. From 2018 to 2022, the market for treating idiopathic pulmonary fibrosis grew at a CAGR of 1%. Several diagnostic methods exist for identifying IPF, and guidelines for diagnosis have been established. Tests such as pulmonary function tests are used to evaluate restrictive lung disease, which is indicated by decreased lung volume (specifically, reduced for...

Management of Chronic Obstructive Pulmonary Disease (COPD ...

Image
3 mm lung nodule :: Article Creator Medications And Their Potential To Cause Increase In 'Lung Nodule' List of Drugs that may cause 'Lung nodule' Advertisement Updated on November 16, 2023 This section presents medications that are known to potentially lead to 'Lung nodule' as a side effect." It's important to note that mild side effects are quite common with medications. Please be aware that the drugs listed here are individual medications and may be part of a broader combination therapy. This information is meant to be a helpful resource but should not replace professional medical advice. If you're concerned about 'Lung nodule', it's best to consult a healthcare professional. In addition to 'Lung nodule', other symptoms or signs might better match your side effect. We have listed these below for your convenience. If you find a symptom ...

Postoperative Pulmonary Complications and Perioperative ...

Image
atelectasis copd :: Article Creator Coping With End-Stage COPD End-stage COPD is the most severe stage of chronic obstructive pulmonary disease. During this stage, symptoms worsen, and a flare could become life threatening. Chronic obstructive pulmonary disease (COPD) is a progressive condition that affects a person's ability to breathe well. It encompasses several conditions, including emphysema and chronic bronchitis. In addition to a reduced ability to breathe in and out fully, symptoms can include a chronic cough and increased sputum production. Read on to learn about ways to ease end-stage COPD symptoms and factors that may affect your outlook if you have this condition. End-stage COPD is the most severe stage of COPD. It's also called very severe COPD. During this stage, symptoms such as coughing and shortness of breath worsen and can become life threatening. COPD has four stages, and your airflow becomes more l...